NADIR PSA and time to NADIR PSA after radiotherapy +/- androgen deprivation as a predictor of prostate cancer outcome.

被引：0
|
作者：
Sancho Pardo, G.
GAmez de Segura, G.
Gich, I.
FarrA, N.
Membrive, I.
Trilla, J.
RosellA, A.
机构：
[1] Hosp Santa Creu & Santa Pau, Dept Radiotherapy & Radiat Oncol, Barcelona, Spain
[2] Hosp Santa Creu & Santa Pau, Serv Clin Epidemiol & Publ Hlth, Barcelona, Spain
来源：
RADIOTHERAPY AND ONCOLOGY | 2006年 / 81卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1106
引用
收藏
页码：S451 / S452
页数：2
相关论文
共 50 条
  • [1] PSA nadir after radiotherapy for prostate cancer is a predictor of outcome
    Nature Clinical Practice Oncology, 2006, 3 (7): : 352 - 352
  • [2] PSA nadir after radiotherapy for prostate cancer is a predictor of outcome
    Nature Clinical Practice Urology, 2006, 3 (7): : 352 - 353
  • [3] Survival is associated with time to reach PSA nadir (DAN) and the ratio DAN/nadir value after androgen deprivation for prostate cancer
    Gagnat, A.
    Larre, S.
    Fromont, G.
    Pires, C.
    Dore, B.
    Irani, J.
    PROGRES EN UROLOGIE, 2011, 21 (05): : 341 - 348
  • [4] Impact of Prostate-Specific Antigen (PSA) Nadir and Time to PSA Nadir on Disease Progression in Prostate Cancer Treated With Androgen-Deprivation Therapy
    Huang, Shu-Pin
    Bao, Bo-Ying
    Wu, Ming-Tsang
    Choueiri, Toni K.
    Goggins, William B.
    Huang, Chao-Yuan
    Pu, Yeong-Shiau
    Yu, Chia-Cheng
    Huang, Chun-Hsiung
    PROSTATE, 2011, 71 (11): : 1189 - 1197
  • [5] Nadir PSA level and time to PSA nadir following primary androgen deprivation therapy are the early survival predictors for prostate cancer patients with bone metastasis
    T Sasaki
    T Onishi
    A Hoshina
    Prostate Cancer and Prostatic Diseases, 2011, 14 : 248 - 252
  • [6] Nadir PSA level and time to PSA nadir following primary androgen deprivation therapy are the early survival predictors for prostate cancer patients with bone metastasis
    Sasaki, T.
    Onishi, T.
    Hoshina, A.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2011, 14 (03) : 248 - 252
  • [7] Nadir PSA level and time to nadir PSA are prognostic factors in patients with metastatic prostate cancer
    Tomioka, Atsushi
    Tanaka, Nobumichi
    Yoshikawa, Motokiyo
    Miyake, Makito
    Anai, Satoshi
    Chihara, Yoshitomo
    Okajima, Eijiro
    Hirayama, Akihide
    Hirao, Yoshihiko
    Fujimoto, Kiyohide
    BMC UROLOGY, 2014, 14
  • [8] Nadir PSA level and time to nadir PSA are prognostic factors in patients with metastatic prostate cancer
    Atsushi Tomioka
    Nobumichi Tanaka
    Motokiyo Yoshikawa
    Makito Miyake
    Satoshi Anai
    Yoshitomo Chihara
    Eijiro Okajima
    Akihide Hirayama
    Yoshihiko Hirao
    Kiyohide Fujimoto
    BMC Urology, 14
  • [9] Prognostic value of initial PSA, PSA Nadir and time to Nadir PSA for biochemical failure in patients with intermediate-risk prostate cancer treated with radiation therapy without androgen deprivation
    Patel, N.
    Souhami, L.
    Mansure, J. J.
    Faria, S.
    Duclos, M.
    Shenouda, G.
    David, M.
    Cury, F. L.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S710 - S710
  • [10] PSA nadir and time to PSA nadir during initial androgen deprivation therapy as prognostic factors in metastatic castration-resistance prostate cancer patients treated with docetaxel
    Shi, Xinyu
    Pei, Xinqi
    Fan, Junjie
    Liu, Tianjie
    Zhang, Dize
    Yang, Tao
    Wu, Kaijie
    He, Dalin
    Li, Lei
    ANDROLOGIA, 2021, 53 (04)
12345